U.S. FDA Approves Updated Indication for WINREVAIR in Adults with Pulmonary Arterial Hypertension Based on Phase 3 ZENITH Study 21h
eschbach's Shiftconnector® Helps Power Merck's Visual Factory to Drive Greater Transparency, Agility, and Supply Chain Resilience 23 October
Merck to Present New Data from Its Innovative Cardio-Pulmonary Pipeline and Portfolio at AHA Scientific Sessions 2025 23 October
